IP Library Granted Patent US 8,748,173
Granted Patent B2
US 8,748,173 · App. 11/601,133 · Granted Jun 10, 2014

Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof

Inventor: John F. Kearney (Birmingham, AL)
Assignee: UAB Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,748,173
App. No.
11/601,133
Granted
Jun 10, 2014
Kind
B2
Abstract

The present invention provides monoclonal antibodies which are highly specific for Bacillus spores. Also provided are peptides derived from those monoclonal antibodies. Both the antibodies and peptides are highly specific and can discriminate between spores of potentially lethal organisms such as Bacillus anthracis and other harmless but closely related bacilli and provide a very powerful tool in the construction of detection instruments as counter measures.

Claims (11)

1. A method of preparing a monoclonal IgG antibody specific for Bacillus anthracis spores, comprising the steps of:

immunizing an animal with unfixed Bacillus anthracis spores; and

fusing lymph nodes located at the draining site of the immunization of said animal with a myeloma cell to produce a hybridoma cell that produces a monoclonal antibody specific for Bacillus anthracis spores.

2. The method of claim 1 , wherein said animal is a mouse.

3. A method of detecting Bacillus anthracis spores in a field sample using a monoclonal IgG antibody specific for said spores, comprising the steps of:

contacting said sample with a monoclonal antibody specific for Bacillus anthracis spores, wherein the monoclonal antibody is prepared by a method comprising immunizing an animal with unfixed Bacillus anthracis spores; and

detecting the presence of the monoclonal antibody, wherein the presence of the monoclonal antibody indicates the presence of spores.

4. The method of claim 1 , wherein the unfixed spore is irradiated prior to immunizing the animal.

5. A method of detecting Bacillus anthracis spores in a field sample using a monoclonal antibody specific for said spores, comprising the step of:

contacting said sample with a monoclonal antibody prepared by the method of claim 1 ; and

detecting the presence of the monoclonal antibody, wherein the presence of the monoclonal antibody indicates the presence of spores.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 18, 2020
From: UNIVERSITY OF ALABAMA AT BIRMINGHAM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 054474/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: KEARNEY, JOHN F.
To: UAB RESEARCH FOUNDATION
Reel/Frame 032646/0448 →
CONFIRMATORY LICENSE Recorded Sep 3, 2010
From: UNIVERSITY OF ALABAMA AT BIRMINGHAM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024939/0377 →
Continuity (3)
Continuation 11171518 · Jul 1, 2005
Continuation 09069628 · Apr 29, 1998
Related Publication 20070259387A1 · Nov 8, 2007